DeepMed Research

JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder
Nicotine Dependence

Interventions: Drug: Transdermal Nicotine Patch
Drug: Placebo
Drug: Lis-dexamphetamine (Vyvanse)

First Posted Date: 2008-08-15

Last Posted Date: 2018-11-30

Lead Sponsor: Duke University

Target Recruit Count: 32

Registration Number: NCT00736255

Locations: 🇺🇸
Duke Attention Deficit Hyperactivity Disorder (ADHD) Program, Durham, North Carolina, United States

Multimodality Phase II Study in Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Docetaxel
Drug: Sunitinib
Radiation: EBXRT

First Posted Date: 2008-08-14

Last Posted Date: 2015-12-23

Lead Sponsor: Duke University

Target Recruit Count: 36

Registration Number: NCT00734851

Locations: 🇺🇸
The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy

Phase 4

Completed

Conditions: Postoperative Nausea and Vomiting

Interventions: Drug: Ondansetron + Dexamethasone
Drug: Aprepitant + Dexamethasone

First Posted Date: 2008-08-14

Last Posted Date: 2017-03-13

Lead Sponsor: Duke University

Target Recruit Count: 115

Registration Number: NCT00734929

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Combining Objective and Subjective Sedation Assessment Tools

Not Applicable

Completed

Conditions: Critical Illness

Interventions: Device: Bispectral Index (BIS) Monitor

First Posted Date: 2008-08-14

Last Posted Date: 2013-03-29

Lead Sponsor: Duke University

Target Recruit Count: 300

Registration Number: NCT00734409

Locations: 🇺🇸
Duke University Health System, Durham, North Carolina, United States

AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study

Completed

Conditions: Age Related Macular Degeneration

First Posted Date: 2008-08-14

Last Posted Date: 2023-04-19

Lead Sponsor: Duke University

Target Recruit Count: 470

Registration Number: NCT00734487

Locations: 🇺🇸
Emory University Eye Center, Atlanta, Georgia, United States
🇺🇸
National Eye Institute, Bethesda, Maryland, United States
🇺🇸
Duke University Eye Center, Durham, North Carolina, United States

and more 1 locations

An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: 49-channel optical spectrometer

First Posted Date: 2008-08-14

Last Posted Date: 2020-05-15

Lead Sponsor: Duke University

Target Recruit Count: 485

Registration Number: NCT00734955

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Bortezomib With Melphalan and Prednisone for Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Bortezomib
Drug: Melphalan
Drug: Prednisone

First Posted Date: 2008-08-14

Last Posted Date: 2023-11-07

Lead Sponsor: Duke University

Target Recruit Count: 45

Registration Number: NCT00734149

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II

Phase 3

Completed

Conditions: Cigarette Smoking

Interventions: Drug: Nicotine Patch

First Posted Date: 2008-08-14

Last Posted Date: 2014-07-15

Lead Sponsor: Duke University

Target Recruit Count: 479

Registration Number: NCT00734617

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Avastin
Drug: Tarceva
Radiation: Radiation Therapy

First Posted Date: 2008-08-14

Last Posted Date: 2015-06-18

Lead Sponsor: Duke University

Target Recruit Count: 12

Registration Number: NCT00735306

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Partner-Assisted Emotional Disclosure for GI Cancer

Not Applicable

Completed

Conditions: Cancer of the GI System-stages II III and IV

Interventions: Behavioral: Partner-assisted emotional disclosure
Behavioral: Cancer Education

First Posted Date: 2008-08-14

Last Posted Date: 2023-10-26

Lead Sponsor: Duke University

Target Recruit Count: 300

Registration Number: NCT00734513

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy